No Data
No Data
No Data
The Tokyo Stock Exchange Gross Market 250 index rebounded significantly, driven by large cap stocks.
Tokyo Stock Exchange Growth Market Index 833.73 +25.69 / volume 0.2 billion 8.38 million shares / trading value 116 billion yen Tokyo Stock Exchange Growth Market 250 Index 653.27 +21.13 / volume 0.1 billion 40.66 million shares / trading value 97.9 billion yen Today's growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index rebounded significantly. The number of rising stocks is 484, the number of falling stocks is 74, unchanged is 22. The US stock market rose on the 11th. Dow Jones Industrial Average rose by 124.75 dollars (
Stocks that moved the previous day part1 Edge Technology, R Planner, Prodelight, etc.
Stock name <code> 10-day closing price ⇒ previous day comparison stream <3071> 99 - Downward revision of financial estimates for the fiscal year ending 2025. Appirits <4174> 740 - Downward revision of profit estimates for the fiscal year ending 2025. Canvas <4575> 892 +60 Received patent evaluation from the US Patent Office for IDO/TDO inhibitors. Edge Technology <4268> 737 +100 Continuing movement to the TOB price (841 yen). Earl Planner <2983> 1145 +1
CANBAS ranked in and received a patent assessment from the Japanese Patent Office for its IDO/TDO inhibitor.
CANBAS <4575> has ranked in (as of 13:32). In the afternoon of today, Shizuoka Prefectural University Pharmaceutical Discovery Center, the company's collaborative research partner, announced that they have received a patent evaluation from the Japan Patent Office for the anti-cancer drug candidate, the IDO/TDO inhibitor being developed, which has become a buying clue material. The impact on this fiscal year's performance due to the receipt of the patent evaluation is not significant, but it is expected to contribute to the improvement of the long-term corporate value, such as the expansion of the drug discovery pipeline.
Individual investor, Yugetsu Yuken: The focus on australian small/mid cap stocks is reviving, drawing even more attention to biotech stocks! [FISCO Social Reporter]
The following is a comment written by individual investor Yuukai from FISCO Social Reporter (Blog: Profitable Stock Information "Nekodanna's Infinite Sky of Stocks"). At FISCO, we strive to collaborate with individuals who actively disseminate information to deliver a wide range of information to investors. -----------※ After the report that the Ministry of Economy, Trade and Industry is compiling an action plan for the expansion of the bio industry on September 2, 2024 at 13:00, bio-related stocks have gained wide attention.
Learning Aid, D&M Company, etc.
<184A> Gabieaid Co., Ltd. Morgan Stanley MUFG Securities Co., Ltd. Shareholding ratio -% → 5.08% Reporting obligation start date 08/30/2024 <189A> D&M Company Morgan Stanley MUFG Securities Co., Ltd. Shareholding ratio 5.18% → 0.27% Reporting obligation start date 08/30/2024 <2586> Frutta Fruttaebo Fund (Evo Fund) Shareholding ratio
SBI SECURITIES increases its stake in CanBas(4575.JP) to 6.1%
On Sep 5, SBI SECURITIES submitted the Change Report to Ministry of Finance. The report shows that SBI SECURITIES increased their holdings in $CanBas(4575.JP)$, with their joint shareholding ratio
No Data
No Data